Every detail inside SKNV’s FDA-Registered 503B Outsourcing Facility has a purpose — from the controlled manufacturing environments and in-house laboratory systems to the USP-grade water purification that took over a year to validate. This is where your patients’ medications are made.
What you see in this video is a working FDA-Registered 503B Outsourcing Facility — 37,500 square feet of contiguous, purpose-built manufacturing space designed from the ground up to meet and exceed CGMP standards for dermatology.
Every material is sourced and tested before it enters production. Every batch is prepared, tested, and documented by trained professionals working in controlled sterile and non-sterile environments. Environmental conditions — air quality, pressure, and particulate levels — are continuously monitored to ensure consistency from batch to batch. Quality is built into the process from the beginning.
Even the water used in manufacturing is purified through a highly specialized USP-grade system — one that took more than a year to design, install, and validate. At the formulation level, there is no such thing as a minor detail.
SKNV’s facility was built to pharmaceutical-grade standards from the ground up. In-house laboratory capabilities cover full quality control, microbiology, and raw material testing — so nothing is outsourced, nothing is unknown, and every step is traceable.
Large-batch CGMP manufacturing, continuous environmental monitoring, and validated systems at every stage produce the same quality medication every time. Your patients are not receiving formulations that vary run to run.
SKNV controls every stage of the process — manufacturing, quality, labeling, and fulfillment — within one organization. The medication you prescribe and dispense carries a documented chain of quality from raw input to labeled container.
SKNV is an FDA-Registered 503B Outsourcing Facility, operating under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act). This classification was created to establish a higher-accountability category of medication manufacturers — one built on federal oversight, rigorous quality standards, and the infrastructure to support providers at scale.
This classification governs a specific category of medication manufacturers that:
Being a U.S. FDA-Registered 503B Outsourcing Facility gives SKNV clear advantages over traditional compounding pharmacies — advantages that are structural, not incidental.
We comply with strict safety and quality assurance guidelines regulated by both the FDA and state boards of pharmacy, following CGMP standards for facility design, monitoring, and control.
Our high-quality compounded medications are produced in large batches, no patient-specific prescription required — supporting consistent supply and reliable availability for your practice.
Practices can dispense directly from their office. Patients receive their prescribed medication at the time of their visit — no external pharmacy delays.
There are no exclusive benefits of 503A Compounding Pharmacies. A 503B is the clear choice and advantage for practices focused on patient convenience and Rx safety.
The regulatory difference between a 503B Outsourcing Facility and a 503A Compounding Pharmacy is significant for any dermatology practice evaluating a compounding partner. Download the complete comparison.
